← Leaderboards
Alexander V Kabanov
University Of Nebraska Medical Center
$28,176,125
Attributed
$31,792,942
Total exposure
30
Grants
30
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$40,384,709 · 31
By mechanism
P20$14,080,175 · 11
R01$12,276,875 · 6
U01$4,839,275 · 2
T32$3,996,196 · 1
U54$2,359,051 · 1
R21$1,959,697 · 4
Top collaborators
- William A Banks6 shared
- Tatiana K Bronich5 shared
- Rihe Liu5 shared
- William C Zamboni5 shared
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsCopolymerPharmaceutical PreparationsDrug Delivery SystemsTumorNanotechnologyCellsIn VivoResearch PersonnelChemotherapyIn VitroPolymersResponseMouse ModelBaseDrug KineticsLeadPluronicsMicellesSafetyPaclitaxelTechnologyAnimalsAffect
Grant awards (96)
Discovering Fusobacterium nucleatum's Impact on Breast Cancer Progression and Treatment with POx Micelle Technology$399,829
R21 · FY2025 · CA · contact PI
TOWARD TRANSLATION OF NANFORMULATED PACLITAXEL-PLATINUM COMBINATION$582,405
R01 · FY2024 · CA · contact PI
CAROLINA CANCER NANOTECHNOLOGY TRAINING PROGRAM (C-CNTP)$520,560
T32 · FY2024 · CA · contact PI
TOWARD TRANSLATION OF NANFORMULATED PACLITAXEL-PLATINUM COMBINATION$496,337
R01 · FY2023 · CA · contact PI
Naturally Targeted Exosomal TLR7/8 Agonist for Immunotherapy of Medulloblastoma$427,625
R21 · FY2023 · NS · contact PI
CAROLINA CANCER NANOTECHNOLOGY TRAINING PROGRAM (C-CNTP)$388,592
T32 · FY2023 · CA · contact PI
TOWARD TRANSLATION OF NANFORMULATED PACLITAXEL-PLATINUM COMBINATION$600,798
R01 · FY2022 · CA · contact PI
CAROLINA CANCER NANOTECHNOLOGY TRAINING PROGRAM (C-CNTP)$421,267
T32 · FY2022 · CA · contact PI
TOWARD TRANSLATION OF NANFORMULATED PACLITAXEL-PLATINUM COMBINATION$117,913
R01 · FY2022 · CA · contact PI
Diversity Supplement - TOWARD TRANSLATION OF NANFORMULATED PACLITAXEL-PLATINUM COMBINATION$50,133
R01 · FY2022 · CA · contact PI
TOWARD TRANSLATION OF NANFORMULATED PACLITAXEL-PLATINUM COMBINATION$613,059
R01 · FY2021 · CA · contact PI
CAROLINA CANCER NANOTECHNOLOGY TRAINING PROGRAM (C-CNTP)$424,725
T32 · FY2021 · CA · contact PI
CAROLINA CANCER NANOTECHNOLOGY TRAINING PROGRAM (C-CNTP)$467,108
T32 · FY2020 · CA · contact PI
Targeted Core Shell Nanogels for Triple Negative Breast Cancer$545,618
U01 · FY2019 · CA · contact PI
Project 4:High Capacity Polymeric Micelle Therapeutics for Lung Cancer$443,291
U54 · FY2019 · CA · contact PI
CAROLINA CANCER NANOTECHNOLOGY TRAINING PROGRAM (C-CNTP)$379,286
T32 · FY2019 · CA · contact PI
Liposomal Doxorubicin and Pluronic Combination for Cancer Therapy$334,212
R01 · FY2019 · CA · contact PI
Targeted Magneto-Mechanic Nanotherapeutics for Cancer$113,823
R21 · FY2019 · CA · contact PI
Targeted Core Shell Nanogels for Triple Negative Breast Cancer$562,533
U01 · FY2018 · CA · contact PI
Project 4:High Capacity Polymeric Micelle Therapeutics for Lung Cancer$453,374
U54 · FY2018 · CA · contact PI
CAROLINA CANCER NANOTECHNOLOGY TRAINING PROGRAM (C-CNTP)$409,752
T32 · FY2018 · CA · contact PI
Liposomal Doxorubicin and Pluronic Combination for Cancer Therapy$344,549
R01 · FY2018 · CA · contact PI
Targeted Magneto-Mechanic Nanotherapeutics for Cancer$117,468
R21 · FY2018 · CA · contact PI
Targeted Core Shell Nanogels for Triple Negative Breast Cancer$562,542
U01 · FY2017 · CA · contact PI
Project 4:High Capacity Polymeric Micelle Therapeutics for Lung Cancer$505,472
U54 · FY2017 · CA · contact PI
CAROLINA CANCER NANOTECHNOLOGY TRAINING PROGRAM (C-CNTP)$388,701
T32 · FY2017 · CA · contact PI
Liposomal Doxorubicin and Pluronic Combination for Cancer Therapy$344,549
R01 · FY2017 · CA · contact PI
Targeted Magneto-Mechanic Nanotherapeutics for Cancer$117,589
R21 · FY2017 · CA · contact PI
2017 Cancer Nanotechnology Gordon Research Conference and Gordon Research Seminar$2,500
R13 · FY2017 · CA · contact PI
Targeted Core Shell Nanogels for Triple Negative Breast Cancer$562,542
U01 · FY2016 · CA · contact PI
Project 4:High Capacity Polymeric Micelle Therapeutics for Lung Cancer$503,540
U54 · FY2016 · CA · contact PI
CAROLINA CANCER NANOTECHNOLOGY TRAINING PROGRAM (C-CNTP)$395,375
T32 · FY2016 · CA · contact PI
Nanoformulation of the BDNF for treatment of stroke$372,147
R21 · FY2016 · NS · contact PI
Liposomal Doxorubicin and Pluronic Combination for Cancer Therapy$344,549
R01 · FY2016 · CA · contact PI
Nasal Leptin - Polymer Conjugate for Treatment of Obesity$215,843
R41 · FY2016 · DK · contact PI
Targeted Core Shell Nanogels for Triple Negative Breast Cancer$575,542
U01 · FY2015 · CA · contact PI
Project 4:High Capacity Polymeric Micelle Therapeutics for Lung Cancer$453,374
U54 · FY2015 · CA · contact PI
Nanoformulation of the BDNF for treatment of stroke$411,216
R21 · FY2015 · NS · contact PI
Liposomal Doxorubicin and Pluronic Combination for Cancer Therapy$344,549
R01 · FY2015 · CA · contact PI
CAROLINA CANCER NANOTECHNOLOGY TRAINING PROGRAM (C-CNTP)$200,830
T32 · FY2015 · CA · contact PI
High Capacity Nanocarriers for Cancer Chemotherapeutics$379,186
U01 · FY2014 · CA · contact PI
Polypeptide Modification for Enhanced Brain Delivery$340,541
R01 · FY2014 · NS · contact PI
High Capacity Nanocarriers for Cancer Chemotherapeutics$375,556
U01 · FY2013 · CA · contact PI
Polypeptide Modification for Enhanced Brain Delivery$334,428
R01 · FY2013 · NS · contact PI
High Capacity Nanocarriers for Cancer Chemotherapeutics$421,035
U01 · FY2012 · CA · contact PI
Polypeptide Modification for Enhanced Brain Delivery$247,416
R01 · FY2012 · NS · contact PI
Nanoformulation Manufacture and Characterization$154,296
P01 · FY2012 · DA · contact PI
Polypeptide Modification for Enhanced Brain Delivery$104,135
R01 · FY2012 · NS · contact PI
Nebraska Center for Nanomedicine$2,167,099
P20 · FY2011 · RR · contact PI
NEBRASKA CENTER FOR NANOMEDICINE ADMINISTRATIVE CORE$666,231
P20 · FY2011 · RR · contact PI
High Capacity Nanocarriers for Cancer Chemotherapeutics$410,562
U01 · FY2011 · CA · contact PI
Polypeptide Modification for Enhanced Brain Delivery$355,371
R01 · FY2011 · NS · contact PI
NEW HIRES$297,434
P20 · FY2011 · RR · contact PI
Interactions of Pluronic block copolymers in drug resistant cancer$241,433
R01 · FY2011 · CA · contact PI
Nanoformulation Manufacture and Characterization$239,642
P01 · FY2011 · DA · contact PI
NANOMATERIALS$148,728
P20 · FY2011 · RR · contact PI
Interactions of Pluronic block copolymers in drug resistant cancer$51,185
R01 · FY2011 · CA · contact PI
8th and 9th International Nanomedicine and Drug Delivery Symposiums (NanoDDS'10/1$8,000
R13 · FY2011 · CA · contact PI
Nebraska Center for Nanomedicine$2,188,989
P20 · FY2010 · RR · contact PI
NEBRASKA CENTER FOR NANOMEDICINE ADMINISTRATIVE CORE$686,750
P20 · FY2010 · RR · contact PI
High Capacity Nanocarriers for Cancer Chemotherapeutics$444,159
U01 · FY2010 · CA · contact PI
Polypeptide Modification for Enhanced Brain Delivery$394,299
R01 · FY2010 · NS · contact PI
NEW HIRES$300,439
P20 · FY2010 · RR · contact PI
Interactions of Pluronic block copolymers in drug resistant cancer$248,900
R01 · FY2010 · CA · contact PI
Polymer Based Gene Delivery$246,475
R01 · FY2010 · CA · contact PI
Nanoformulation Manufacture and Characterization$230,159
P01 · FY2010 · DA · contact PI
NANOMATERIALS$150,230
P20 · FY2010 · RR · contact PI
Interactions of Pluronic block copolymers in drug resistant cancer$43,975
R01 · FY2010 · CA · contact PI
Nebraska Center for Nanomedicine$2,152,458
P20 · FY2009 · RR · contact PI
NEBRASKA CENTER FOR NANOMEDICINE ADMINISTRATIVE CORE$675,291
P20 · FY2009 · RR · contact PI
NEW HIRES$295,446
P20 · FY2009 · RR · contact PI
Interactions of Pluronic block copolymers in drug resistant cancer$250,086
R01 · FY2009 · CA · contact PI
Polymer Based Gene Delivery$245,806
R01 · FY2009 · CA · contact PI
NANOMATERIALS$184,638
P20 · FY2009 · RR · contact PI
NEBRASKA CENTER FOR NANOMEDICINE$2,083,221
P20 · FY2008 · RR · contact PI
Nebraska Center for Nanomedicine$2,083,221
P20 · FY2008 · RR · contact PI
Polypeptide modification for enhanced brain delivery$288,196
R01 · FY2008 · NS · contact PI
Polymer Based Gene Delivery$260,726
R01 · FY2008 · CA · contact PI
Interactions of Pluronic block copolymers in drug resistant cancer$250,086
R01 · FY2008 · CA · contact PI
6th International Nanomedicine and Drug Delivery Symposium$10,000
R13 · FY2008 · EB · contact PI
Polymer Based Gene Delivery$295,689
R01 · FY2007 · CA · contact PI
Polypeptide modification for enhanced brain delivery$283,170
R01 · FY2007 · NS · contact PI
Interactions of Pluronic block copolymers in drug resistant cancer$261,836
R01 · FY2007 · CA · contact PI
Polypeptide modification for enhanced brain delivery$346,523
R01 · FY2006 · NS · contact PI
Interactions of Block Copolymers in Blood Brain Barrier$340,921
R01 · FY2006 · NS · contact PI
Polymer Based Gene Delivery$258,376
R01 · FY2006 · CA · contact PI
Fourth International Nanomedicine and Drug Delivery Symposium$13,000
R13 · FY2006 · EB · contact PI
Interactions of Block Copolymers in Blood Brain Barrier$349,125
R01 · FY2005 · NS
Interactions of Block Copolymers in Blood Brain Barrier$349,125
R01 · FY2004 · NS
Pluronic Block Copolymers in Drug Resistant Cancer$218,664
R01 · FY2004 · CA
Interactions of Block Copolymers in Blood Brain Barrier$349,125
R01 · FY2003 · NS
Pluronic Block Copolymers in Drug Resistant Cancer$218,664
R01 · FY2003 · CA
Interactions of Block Copolymers in Blood Brain Barrier$349,125
R01 · FY2002 · NS
Pluronic Block Copolymers in Drug Resistant Cancer$218,664
R01 · FY2002 · CA
Pluronic Block Copolymers in Drug Resistant Cancer$231,099
R01 · FY2001 · CA
INTERACTIONS OF BLOCK COPOLYMERS IN BLOOD BRAIN BARRIERS$130,658
R01 · FY2000 · NS